Ambev's revenue has been broadly flat across the ten-quarter window, moving from $20.0B to $21.6B, while gross margin held a tight 49.8% to 53.7% band with the latest reading at 51.0%, suggesting pricing power and premium mix are resilient against input costs.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has been volatile, with year-over-year changes ranging from -8.2% to +35.2%, while gross margin stayed between 49.8% and 53.7% and net margin fluctuated between 12.0% and 22.8%, suggesting earnings are highly sensitive to timing and currency translation.
Ambev S.A. has trailing and forward P/E ratios of 13.45 and 13.26 respectively, indicating a potentially undervalued stock.
The bullish thesis highlights Ambev's strong position in emerging markets, which offers significant growth potential.
Ambev is focusing on premiumization, which could drive higher margins and revenue growth in its product offerings.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | $0.05+0.0% vs $0.05 | $4.0B-4.8% vs $4.2B |
Q3 2026 Jul 30, 2026 | $0.04+0.0% vs $0.04 | $4.0B-1.9% vs $4.1B |
Q2 2026 May 5, 2026 | $0.05+0.0% vs $0.05 | $4.6B+4.2% vs $4.4B |
Q1 2026 Feb 12, 2026 | $0.05+0.0% vs $0.05 | $5.2B+13.1% vs $4.6B |
Anheuser-Busch InBev SA/NV (NYSE: BUD - Get Free Report) and Ambev (NYSE: ABEV - Get Free Report) are both large-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends and profitability. Dividends Anheuser-Busch InBev SA/NV pays an
I downgrade Ambev from buy to hold due to weak operational trends and limited upside versus sector peers. ABEV's Q3 net revenue missed expectations, with volumes down YoY and gross margin pressured by rising costs. Valuation at 13.5x earnings reflects Brazil's high tax burden and competitive headwinds, making current risk/reward unattractive.
Ambev remains a Buy, with post-election volatility creating a compelling entry point amid resilient fundamentals and strong margin improvements despite cost headwinds. ABEV demonstrates significant pricing power, premiumization growth, and robust free cash flow, supporting shareholder returns. Digital expansion via BEES and Zé Delivery enhances margin protection and taps into younger, high-margin consumer segments.
Ambev NYSE: ABEV reported third-quarter growth in volume, revenue, profitability and normalized earnings, as the brewer cited portfolio gains, commercial execution and cost discipline across its markets.
Benchmark ABEV against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Ambev S.A. (ABEV)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.79 | $43.51B | 15.07 | -1.35% | 17.69% | 17.5% | 8.51% | |
| $83.96 | $162.13B | 24.27 | -0.75% | — | — | 2.74% | |
| $40.33 | $7.56B | 8.44 | -4.18% | 8.09% | 8.54% | 4.77% | |
| $220.64 | $2.3B | -30.88 | 3.69% | -3.47% | -9.81% | — | |
| $95.67 | $411.62B | 28.21 | 1.87% | 28.65% | 39.58% | 2.13% | |
| $141.34 | $193.07B | 17.71 | 2.25% | 11.1% | 50.24% | 3.94% |
Ambev S.A. (ABEV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when ABEV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Ambev S.A. (ABEV) stock FAQ — growth, dividends, profitability & financials explained
Ambev S.A. (ABEV) reported $89.02B in revenue over the trailing twelve months. Revenue was $88.24B in fiscal year 2025. That is 1581% more than the $5.25B of fiscal year 2000.
Ambev S.A. (ABEV) revenue fell by 1.6% over the trailing twelve months, compared with the twelve months before.
Yes. Ambev S.A. (ABEV) earned $15.75B in net income over the trailing twelve months (a 17.7% net margin).
Yes. Ambev S.A. (ABEV) pays a dividend that yields 8.51% at the current price, a high yield.
Ambev S.A. (ABEV) had a return on equity (ROE) of 17.5% over the trailing twelve months. That is above the market's typical 10-15%.
Ambev S.A. (ABEV) generated $24.69B in free cash flow over the trailing twelve months.
